UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) | February 2, 2016 |
SPAN-AMERICA MEDICAL SYSTEMS, INC. |
(Exact name of registrant as specified in its charter) |
South Carolina | 0-11392 | 57-0525804 |
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
70 Commerce Center, Greenville, South Carolina | 29615 |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code | (864) 288-8877 |
N/A |
(Former name or former address, if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
[ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
[ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
[ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 1.01. | Entry into a Material Definitive Agreement. |
On February 2, 2016, Span-America Medical Systems, Inc. (the “Company”) and Nipro Consumer Healthcare, Inc., d/b/a P.J. Noyes Company (“PJ Noyes”), entered into an Amendment No. 1 to License and Distribution Agreement effective February 1, 2016 amending the License and Distribution Agreement effective October 4, 2010 by and between the Company and PJ Noyes to extend the term of the agreement through December 31, 2020.
A copy of the Amendment No. 1 to License and Distribution Agreement is filed herewith as Exhibit 10.1 hereto, and the description of the amendment set forth above is qualified in its entirety by reference to the text thereof which is incorporated herein by reference.
Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits.
Exhibit Number | Description of Exhibit |
| | |
| 10.1 | Amendment No. 1 to License and Distribution Agreement effective February 1, 2016 by and between Nipro Consumer Healthcare, Inc., d/b/a P.J. Noyes Company and Span-America Medical Systems, Inc. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | SPAN-AMERICA MEDICAL SYSTEMS, INC. | |
| | | (Registrant) | |
| | | | |
Date: February 8, 2016 | | | |
| By: | /s/ Richard C. Coggins | |
| | Richard C. Coggins | |
| | Chief Financial Officer | |
EXHIBIT INDEX
Exhibit | Description |
| | |
| 10.1 | Amendment No. 1 to License and Distribution Agreement effective February 1, 2016 by and between Nipro Consumer Healthcare, Inc., d/b/a P.J. Noyes Company and Span-America Medical Systems, Inc. |
